![Wesley Burks, MD, and Edwin Kim, MD](https://news.unchealthcare.org/wp-content/uploads/sites/1159/2020/06/fda-approves-first-drug-for-treatment-of-peanut-allergy-for-children-image2-600x366.jpeg)
January 20, 2022
Oral Immunotherapy Alleviates Peanut Allergy in Some Young Children
This study, called IMPACT, was co-led by A. Wesley Burks, MD, CEO of UNC Health and dean of the UNC School of Medicine. Edwin Kim, MD, is co-author on the paper and leads peanut allergy research at the UNC School of Medicine.